Emmecell has announced positive results from its U.S. multicenter Phase 1 trial evaluating EO2002, a...

A team of experts, convened by the National Institutes of Health (NIH), has defined five essential e...

Melt Pharmaceuticals has reported promising topline results from the pivotal Phase 3 trial of MELT-3...

Ocugen has released encouraging preliminary findings from the Phase 1 portion of its Phase 1/2 OCU41...

A study led by researchers at the University of California, San Diego, reveals that long-term variab...

Alkeus Pharmaceuticals has announced that the FDA has granted Rare Pediatric Disease and Fast Track ...

Samsung Bioepis and Biogen have announced that the European Commission (EC) has approved Opuviz 40 m...

Aldeyra Therapeutics has announced a major milestone as the FDA formally accepted its resubmitted Ne...

The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec have launched a groundbreaking co...

A groundbreaking study from the University of Colorado Anschutz Medical Campus has identified a sign...